BACKGROUND: Biliary atresia (BA) is the most serious liver disease in infants. Diagnosis currently depends on surgical exploration of the biliary tree. Noninvasive tests that distinguish BA from other types of neonatal liver disease are not available. PATIENTS AND METHODS: To identify potential serum biomarkers that classify children with neonatal cholestasis, we performed 2-dimensional difference gel electrophoresis, statistical analysis, and tandem mass spectrometry using serum samples from 19 infants with BA and 19 infants with non-BA neonatal cholestasis. RESULTS: Eleven potential serum biomarkers were found that could in combination classify children with neonatal cholestasis. CONCLUSIONS: Although no single biomarker or imaging test adequately distinguishes BA from other types of neonatal cholestasis, combinations of biomarkers, imaging tests, and noninvasive clinical criteria should be further explored as potential tests for rapid and accurate diagnosis of BA.
BACKGROUND:Biliary atresia (BA) is the most serious liver disease in infants. Diagnosis currently depends on surgical exploration of the biliary tree. Noninvasive tests that distinguish BA from other types of neonatal liver disease are not available. PATIENTS AND METHODS: To identify potential serum biomarkers that classify children with neonatal cholestasis, we performed 2-dimensional difference gel electrophoresis, statistical analysis, and tandem mass spectrometry using serum samples from 19 infants with BA and 19 infants with non-BA neonatal cholestasis. RESULTS: Eleven potential serum biomarkers were found that could in combination classify children with neonatal cholestasis. CONCLUSIONS: Although no single biomarker or imaging test adequately distinguishes BA from other types of neonatal cholestasis, combinations of biomarkers, imaging tests, and noninvasive clinical criteria should be further explored as potential tests for rapid and accurate diagnosis of BA.
Authors: H R Kast; C M Nguyen; C J Sinal; S A Jones; B A Laffitte; K Reue; F J Gonzalez; T M Willson; P A Edwards Journal: Mol Endocrinol Date: 2001-10
Authors: Jorge A Bezerra; Greg Tiao; Frederick C Ryckman; Maria Alonso; Gregg E Sabla; Benjamin Shneider; Ronald J Sokol; Bruce J Aronow Journal: Lancet Date: 2002-11-23 Impact factor: 79.321
Authors: Sharad I Wadhwani; Yumirle P Turmelle; Rosemary Nagy; Jeffrey Lowell; Patrick Dillon; Ross W Shepherd Journal: Pediatrics Date: 2008-04-28 Impact factor: 7.124
Authors: Chatmanee Lertudomphonwanit; Reena Mourya; Lin Fei; Yue Zhang; Sridevi Gutta; Li Yang; Kevin E Bove; Pranavkumar Shivakumar; Jorge A Bezerra Journal: Sci Transl Med Date: 2017-11-22 Impact factor: 17.956